Distribution and Marketing of Drugs

Jurisdictional Comparisons
Erscheinungsjahr 2012
ISBN: 978-0-414-02684-1
Verlag: Sweet & Maxwell

Buch, Englisch, 450 Seiten

Distribution & Promotion of Drugs is the essential reference guide for pharmaceutical companies, legal professionals and marketing companies. Covering over 20 major jurisdictions worldwide this title offers you insight into the laws on drug distribution and promotion, and much more:

Includes contributions from leading local practitioners who are experts in the field
Allows for easy cross-jurisdictional comparisons
Answers pertinent questions of multinational organisations
Provides key information and highlights all of the major aspects of drug distribution and promotion law in major jurisdictions
Facilitates understanding of the diversity of legislation and compliance regarding drug distribution and promotion in the global context
Helps in managing the legal risks associated with distribution and promotion of drugs with the obligations under different national laws
Each chapter includes overviews of the legal regimes regarding distribution and marketing of drugs to consumers and businesses (wholesale), as well as answers to specific questions such as the relevance of industry codes, marketing via social media, provision of samples, engagement with patient organizations, and legal sanctions

Autoren/Hrsg.

Stupp, Eric

Schott, Markus

Dennis, Alison

Fachgebiete

• Rechtswissenschaften Recht, Rechtswissenschaft Allgemein Recht mehrerer Jurisdiktionen, Synopsen
• Wirtschaftswissenschaften Wirtschaftssektoren & Branchen Fertigungsindustrie Pharmaindustrie

Inhaltsverzeichnis

Distribution
Preconditions for Distribution
Distribution to Consumers
Wholesale Distribution

Marketing
Promotion (Marketing)
Marketing to Consumers
Marketing to Professionals
Engagement with Patient Organisation

1. Austria- CMS Reich-Rohrwig Hainz
2. Belgium- CMS Derks Star Busmann
3. China- King & Wood Mallesons
4. Croatia- CMS Reich-Rohrwig Hainz
5. Czech- Republic Baker & McKenzie
6. Denmark- Plesner
7. Finland- Roschier
8. France- Field Fisher Waterhouse LLP
9. Germany- Field Fisher Waterhouse LLP
10. Ireland- Arthur Cox
11. Italy- CMS Derks Star Busmann
12. Japan- Iwata Godo
13. Netherlands- CMS Derks Star Busmann
14. Norway- BAHR
15. Portugal- Morais Leitâo, Galvâo Teles CMS Reich-Rohrwig Hainz
16. Romania- Nestor Nestor Diculescu Kingston Petersen
17. Serbia- CMS Reich-Rohrwig Hainz
18. Slovakia- Baker & McKenzie
19. South Africa- Werksmans Attorneys
20. Spain- URÍA MENÉNDEZ
21. Sweden- MANNHEIMER SWARTLING
22. Switzerland- Bäer & Karrer
23. Thailand- Tilleke & Gibbins
24. Turkey- Mehmet Gün & Partners
25. UK- Field Fisher Waterhouse LLP
26. Vietnam- Tilleke & Gibbins

Über Autor(innen)

EDITORS & EDITORIAL BOARD

Alison Dennis- Field Fisherwaterhouse

Alison Dennis provides intellectual property, commercial and expert regulatory advice to clients in the pharmaceutical, biotech and medical device industries at all stages during the life cycle of their products.
Alison has extensive experience of drafting and negotiating a wide range of specialist agreements for clients in the life sciences sector including strategic alliances, collaborations, clinical trial agreements, technical/quality agreements, tolling, manufacturing, and supply agreements. Alison’s practice also includes advising on the protection and exploitation of intellectual property rights through a variety of different structures, where clients have confirmed that Alison “does a great job” (The Legal 500, 2008).
Alison’s experience includes advising on a wide range of regulatory issues arising in the pharmaceutical, biotech and medical device industries. These include complex issues arising in connection with compliance with the various codes of practice on advertising and promoting pharmaceuticals and medical devices, establishment in the EU, the regulation of clinical trials, the regulation of human tissue use, and dealings with the Medicines and Healthcare products Regulatory Agency (MHRA) and the European Medicines Agency (EMEA).
Alison is a regular speaker at international conferences on compliance issues affecting the pharmaceutical and medical devices industries.
Alison sits on the Legal Committee and the Compliance Working Group of the ABHI (UK trade association for medical devices industry).
Alison regularly lectures at the University of Cambridge as part of its Masters of Bioscience Enterprise on life sciences law.

Eric Supp- Bäer & Karrer

Eric Stupp’s main areas of focus are capital markets, bank regulations, and M&A in the finance sector. He heads the financial services team of Bär & Karrer and advises banks, insurances and other financial institutions in Switzerland and abroad on a regular basis. Furthermore, he advises clients in real estate transactions.

Eric is vice-chairman of the board of directors of Goldman Sachs Bank AG, Zurich, and a member of the boards of other financial institutions and industrial companies.

According to Chambers Europe 2011, clients say that Eric Stupp "is the name we would naturally think of for banking matters". Chambers Global 2011 points out: "A fantastic lawyer with commendable skills in capital markets, Eric Stupp is considered a big asset to the team", adding "Eric Stupp is commended by sources for his general corporate expertise, especially in transactions featuring international companies." The Legal 500 2011 considers him "accessible, practical and very commercial". According to Chambers Global 2012, sources laud his excellent negotiating skills and ability to "judge a situation and know when to give and when to hold back." Chambers Europe 2011 moreover emphasizes his expertise in insolvency and real estate matters and The Legal 500 2012 lists Eric Stupp among the leading lawyers in Switzerland in the banking and finance sector.

Markus Schott- Bäer & Karrer

Markus Schott has broad experience in all kinds of regulatory and administrative law matters including public procurement, public private partnerships, state responsibility, and environmental protection. He advises and represents clients in the banking and finance, insurance, life sciences, food, telecommunications, and infrastructure sectors. He also drafts expert opinions in these fields.

Markus is also specialized in representing clients in commercial litigation and arbitration proceedings.